View of Bone Health During Adjuvant Aromatase Inhibitor Therapy in Non-Metastatic Hormone Receptor-Positive Breast Cancer: from Pathophysiology to Evidence-Based Prevention and Management

Return to Article Details Bone Health During Adjuvant Aromatase Inhibitor Therapy in Non-Metastatic Hormone Receptor-Positive Breast Cancer: from Pathophysiology to Evidence-Based Prevention and Management Download Download PDF